同义名 : | NE-10064 | |
CAS号 : | 149908-53-2 | |
货号 : | A227129 | |
分子式 : | C23H28ClN5O3 | |
纯度 : | 98+% | |
分子量 : | 457.953 | |
MDL号 : | MFCD00867099 | |
存储条件: |
粉末 Sealed in dry,2-8°C 液体 -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
描述 | Azimilide is a class III antiarrhythmic compound, inhibits I(Ks) and I(Kr) in guinea-pig cardiac myocytes and I(Ks) (minK) channels expressed in Xenopus oocytes. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00035490 | Arrhythmia | Phase 3 | Completed | - | - |
NCT00035451 | Atrial Fibrillation | Phase 3 | Completed | - | - |
NCT01097330 | Defibrillators, Implantable ... 展开 >> Tachycardia, Ventricular 收起 << | Phase 3 | Terminated(Anticipated non-fea... 展开 >>sibility of recruitment objectives) 收起 << | December 2014 | United States, Illinois ... 展开 >> Northwestern University Chicago, Illinois, United States, 60611 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Cardiac Arrhythmia Research Foundation Austin, Texas, United States, 78705 United States, Virginia University of Virginia Health System Charlottesville, Virginia, United States, 22908 Canada, Ontario Hamilton Health Sciences Hamilton, Ontario, Canada, L8L 2X2 Southlake Regional Health Centre Newmarket, Ontario, Canada, L3Y 2P9 University of Ottawa Heart Institute Ottawa, Ontario, Canada, K1Y 4W7 Canada, Quebec McGill University Health Center Montreal, Quebec, Canada, H3G 1A4 Canada Institut Universitaire de Cardiologie et Pneumologie de Québec Quebec, Canada, G1V 4G5 China Beijng Fuwai Heart Hospital Beijing, China, 100037 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.18mL 0.44mL 0.22mL |
10.92mL 2.18mL 1.09mL |
21.84mL 4.37mL 2.18mL |
参考文献 |
---|